Previous close | 38.73 |
Open | 38.53 |
Bid | 38.07 x 100 |
Ask | 38.34 x 100 |
Day's range | 38.13 - 39.58 |
52-week range | 12.57 - 42.50 |
Volume | |
Avg. volume | 696,538 |
Market cap | 1.441B |
Beta (5Y monthly) | 1.11 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) just released its latest first-quarter results and things are looking...
Tarsus Pharmaceuticals ( NASDAQ:TARS ) First Quarter 2024 Results Key Financial Results Revenue: US$27.6m (up by...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript May 8, 2024 Tarsus Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Tarsus’s First Quarter 2024 Financial Results Conference Call. As a reminder, this […]